Physiological Role
Copper is a trace element the body can neither synthesize nor store in large quantities. It must be supplied regularly through the diet. Published estimates place the adult body content between 70 and 120 mg, distributed mainly in the liver, brain and muscles.
This metal serves as a cofactor in about a dozen enzymes. Ceruloplasmin, the main copper transport protein in blood, has ferroxidase activity. It oxidizes ferrous iron to ferric iron, a step required for iron binding to transferrin. When this step slows, iron is mobilized less efficiently.
In the blood, about 90% of circulating copper is bound to ceruloplasmin, the rest being carried by albumin and small molecules. Copper is also the cofactor of copper-zinc superoxide dismutase (Cu/Zn-SOD), one of the most active intracellular antioxidant systems. This enzyme neutralizes superoxide radicals produced by cellular metabolism. Copper also participates in melanin synthesis, collagen and elastin formation via lysyl oxidase, and nervous system function.
Reference Ranges
Depending on the biomarker, Singular ranges are based on a synthesis of nutritional or clinical reference points and longevity research. They do not replace your laboratory's reference values or your healthcare professional's advice.
Female
Male
Biological Significance
Serum copper within the optimal range reads first as a position within the usual distribution of adults. This range is a Singular calibration: no publication establishes that one figure within it is preferable to another. Circulating copper, carried at about 90% by ceruloplasmin, is then available for the enzymatic functions that depend on it.
Low values may reflect insufficient dietary intake, reduced absorption or antagonism from excess zinc. Serum copper does follow status changes, but the amplitude of that response is smaller in people who are already well supplied, and its established usefulness is that of a population marker rather than a fine-grained measurement of one person's status. In some individuals, low copper coexists with low iron, as both elements share common metabolic pathways through ceruloplasmin.
Elevated values may result from excessive dietary or supplemental intake, or from an imbalanced copper/zinc ratio. Serum copper also rises in the presence of inflammation, as ceruloplasmin is an acute-phase protein. An elevated value is therefore interpreted alongside an inflammatory marker such as hs-CRP, ideally outside an acute episode. This is also the main limitation of the observational studies listed below: they do not separate what belongs to inflammation from what belongs to copper itself, and a genetic analysis published in 2022 does not reproduce their result. The copper/zinc ratio, calculated from both markers, provides a more nuanced reading than copper alone.
Serum copper trends over time provide more information than a single measurement. Regular monitoring, away from any inflammatory episode, helps distinguish an underlying trend from a one-time variation.
Influencing Factors
Diet. The most concentrated dietary sources of copper include liver, seafood (oysters in particular), nuts, seeds and dark chocolate. A diversified diet generally supplies enough to cover the adequate intake retained in Europe for adults, 1.3 mg per day in women and 1.6 mg in men. The European nutrient reference value, the one used to calculate the percentages shown on labels, is 1 mg per day.
Zinc. In the laboratory, zinc causes a protein to appear in the intestinal wall that captures copper. High zinc intake can therefore reduce copper absorption. This antagonism is why Singular measures both markers together and calculates their ratio.
Intestinal absorption. Conditions reducing absorption (bariatric surgery, chronic intestinal disorders) can decrease copper assimilation. The body compensates in part on its own: in young men followed in a metabolic unit, the share of dietary copper actually absorbed rises from 12% when intake is high to 36% when it is adequate, and to 56% when it is low. Very high-dose vitamin C, on the order of 1,500 mg per day, has been studied on this ground: in young adults it reduces the activity of an enzyme carried by ceruloplasmin, without serum copper itself varying significantly.
Inflammation and hormones. Serum copper rises in the presence of inflammation, as the ceruloplasmin that carries it is an acute-phase protein. Estrogens also increase hepatic ceruloplasmin synthesis: women on hormonal contraception or during pregnancy present higher serum copper levels. A blood draw away from an acute inflammatory episode provides a more representative measurement of baseline status.
Tobacco. Smoking is accompanied by higher serum copper concentrations, which moves an individual value away from its baseline level.
Physical activity. Intense prolonged exercise can transiently alter trace element metabolism. A resting blood draw, well after intense effort, provides a more representative measurement of baseline status.
Age. Copper requirements and circulating concentrations evolve with age. Older adults are more likely to have insufficient intake due to less diversified diets and reduced intestinal absorption.
Supplementation. Copper bisglycinate is the form used in the Singular formula. Supplementation adapted to measured status contributes to maintaining copper-zinc balance.
In the Singular Formula
Serum copper is an active parameter in the Singular formulation engine. Its level directly determines the inclusion and dosage of copper in the personalized formula.
When copper falls in the low or very low zone, the formulation engine includes copper (copper bisglycinate) at its highest dosage. Copper contributes to normal iron transport in the body. Once status reaches the optimal zone, no rule adds copper and the formula contains none.
The copper/zinc ratio plays a complementary role. Copper intake is set from the copper value. Copper follows its own reading, from its own value. This cross-referencing logic illustrates Singular's systemic approach: each marker is interpreted within its overall biological context.
Zinc, measured in parallel by Singular, reduces copper absorption at high intake. Ferritin and transferrin saturation complement the profile by evaluating iron status, whose mobilization partly depends on copper through ceruloplasmin.
Scientific Studies
| Authors | Year | Type | Journal | |
|---|---|---|---|---|
| Zhao H et al. | 2024 | Meta-analysis | Environmental Pollution | View on PubMed |
Circulating copper levels and the risk of cardio-cerebrovascular diseases and cardiovascular and all-cause mortality: A systematic review and meta-analysis of longitudinal studies This meta-analysis of 17 cohort studies (47,813 participants) associates elevated circulating copper with higher all-cause mortality (relative risk 1.56), higher cardiovascular mortality and an increased risk of stroke. No association is found, however, with the occurrence of myocardial infarction. | ||||
| Muñoz-Bravo C et al. | 2023 | Meta-analysis | Frontiers in Cardiovascular Medicine | View on PubMed |
Serum copper levels and risk of major adverse cardiovascular events: a systematic review and meta-analysis This systematic review with meta-analysis of 16 studies (41,322 participants) associates elevated serum copper with the risk of major adverse cardiovascular events. The corpus mixes ten prospective cohorts and six case-control studies, whose result may reflect a rise following the event rather than the reverse. | ||||
| Malavolta M et al. | 2010 | Cohort Study | Biogerontology | View on PubMed |
Plasma copper/zinc ratio: an inflammatory/nutritional biomarker as predictor of all-cause mortality in elderly population The plasma copper/zinc ratio is associated with inflammatory markers and predicts all-cause mortality at 3.5 years in individuals over 70. The article concerns the ratio rather than copper alone, and attributes its drift with age mainly to the progressive decline of plasma zinc. | ||||
| Li X et al. | 2023 | Cohort Study | BMC Public Health | View on PubMed |
Association of serum copper (Cu) with cardiovascular mortality and all-cause mortality in a general population: a prospective cohort study In this prospective NHANES-based cohort, participants in the highest serum copper tertile (from 19.84 µmol/L) show higher all-cause and cardiovascular mortality than those in the lowest tertile (below 16.31 µmol/L). The cardiovascular estimate rests on 96 deaths and its confidence interval is very wide. The middle tertile does not differ from the lowest. | ||||
| Mocchegiani E et al. | 2012 | Cohort Study | Age | View on PubMed |
Cu to Zn ratio, physical function, disability, and mortality risk in older elderly (ilSIRENTE study) The ilSIRENTE study followed 346 people aged 80 and over from a single Italian valley for four years. Those in the highest copper/zinc ratio tertile show a 1.92-fold mortality risk, with a confidence interval whose lower bound is close to no effect. The ratio is more informative there than either of its two constituents taken separately. | ||||
| Altarelli M et al. | 2019 | Review | Nutrition in Clinical Practice | View on PubMed |
Copper Deficiency: Causes, Manifestations, and Treatment This review describes the causes, hematological and neurological manifestations, and management options for severely lowered copper status. Gastric bypass surgery, which reduces absorption, has become a frequent cause, alongside unsupplemented parenteral nutrition and therapeutic zinc excess. | ||||
| Harvey LJ et al. | 2009 | Review | American Journal of Clinical Nutrition | View on PubMed |
Methods of assessment of copper status in humans: a systematic review This systematic review of 16 studies (288 participants in total) compares methods for assessing copper status in humans. Serum copper reflects status changes there, with smaller changes in people who are already well supplied, and its usefulness is established at population level. The authors describe all included studies as small and at high risk of bias, and recall that no copper status marker is recognized today. | ||||
| Jäger S et al. | 2022 | Observational Study | Human Molecular Genetics | View on PubMed |
Blood copper and risk of cardiometabolic diseases: a Mendelian randomization study This analysis uses genetic variants associated with blood copper as proxies for exposure, an approach less sensitive than cohorts to inflammation and lifestyle. Genetically higher copper is associated there with a slightly lower risk of coronary artery disease and lower systolic blood pressure. The authors stress that this result contrasts with observational evidence. | ||||